Xcovery Vision LLC

Xcovery Vision LLC is repurposing an anti-angiogenic cancer drug to treat wet age-related macular degeneration. The pharmacokinetics suggest the compound can be delivered orally with no adverse events and still reach the back of the eye in sufficient quantities to stop the growth of blood vessels that is the hallmark of wet AMD.